Burning Rock Biotech Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BNR research report →
About the company
Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Its operations are structured across three key segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company leverages next-generation sequencing (NGS) technology to offer a diverse portfolio of tests designed to guide therapeutic decisions and predict prognoses for a wide array of cancer types.
- CEO
- Yusheng Han
- IPO
- 2020
- Employees
- 674
- HQ
- Guangzhou, CN
Price Chart
- Market Cap
- $10.38M
- P/E
- -1.18
- P/S
- 0.14
- P/B
- 0.14
- EV/EBITDA
- 14.06
- Div Yield
- 0.00%
- Gross Margin
- 74.55%
- Op Margin
- -11.37%
- Net Margin
- -11.53%
- ROE
- -10.96%
- ROIC
- -10.10%
- Revenue
- $539.57M · 4.60%
- Net Income
- $-55,346,000 · 84.03%
- EPS
- $-49.60 · -47.31%
- Op Income
- $-54,845,000
- FCF YoY
- 65.70%
- 52W High
- $41.72
- 52W Low
- $3.31
- 50D MA
- $12.80
- 200D MA
- $17.62
- Beta
- 1.33
- Avg Volume
- 23.28K
Get TickerSpark's AI analysis on BNR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Han Yusheng | buy | 24,900 |
| Jun 24, 26 | Han Yusheng | buy | 250,000 |
| Jun 23, 26 | Han Yusheng | buy | 5,990 |
| Jun 22, 26 | Han Yusheng | buy | 104,650 |
| Jun 16, 26 | Han Yusheng | buy | 111,110 |
| Jun 12, 26 | Han Yusheng | buy | 210,000 |
| Jun 11, 26 | Han Yusheng | buy | 24,760 |
| Mar 31, 26 | Han Yusheng | buy | 314,870 |
| Mar 18, 26 | DENG FENG | other | 0 |
| Mar 18, 26 | DENG FENG | other | 0 |
Our BNR coverage
Recent articles, reports, and earnings notes.
No research on BNR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BNR report →Similar companies
Peers in the same neighborhood.